Advertisement

Loading...

Uscom Limited

UCM.AXASX
Healthcare
Medical - Devices
$0.01
$0.001(9.09%)
Australian Market is Open • 15:49

Uscom Limited Fundamental Analysis

Uscom Limited (UCM.AX) shows weak financial fundamentals with a PE ratio of -0.71, profit margin of -1.28%, and ROE of -3.58%. The company generates $0.0B in annual revenue with weak year-over-year growth of -30.80%.

Key Strengths

Cash Position41.42%
PEG Ratio0.03

Areas of Concern

ROE-3.58%
Operating Margin-1.45%
Current Ratio0.95
We analyze UCM.AX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 131.7/100 based on profitability, valuation, growth, and balance sheet metrics. The A grade reflects excellent fundamentals and strong overall stability.

Fundamental Health Score

A
131.7/100

We analyze UCM.AX's fundamental strength across five key dimensions:

Efficiency Score

Weak

UCM.AX struggles to generate sufficient returns from assets.

ROA > 10%
-1.02%

Valuation Score

Excellent

UCM.AX trades at attractive valuation levels.

PE < 25
-0.71
PEG Ratio < 2
0.03

Growth Score

Weak

UCM.AX faces weak or negative growth trends.

Revenue Growth > 5%
-30.80%
EPS Growth > 10%
-53.39%

Financial Health Score

Moderate

UCM.AX shows balanced financial health with some risks.

Debt/Equity < 1
-59.22
Current Ratio > 1
0.95

Profitability Score

Weak

UCM.AX struggles to sustain strong margins.

ROE > 15%
-358.43%
Net Margin ≥ 15%
-1.28%
Positive Free Cash Flow
No

Key Financial Metrics

Is UCM.AX Expensive or Cheap?

P/E Ratio

UCM.AX trades at -0.71 times earnings. This suggests potential undervaluation.

-0.71

PEG Ratio

When adjusting for growth, UCM.AX's PEG of 0.03 indicates potential undervaluation.

0.03

Price to Book

The market values Uscom Limited at -61.05 times its book value. This may indicate undervaluation.

-61.05

EV/EBITDA

Enterprise value stands at -0.60 times EBITDA. This is generally considered low.

-0.60

How Well Does UCM.AX Make Money?

Net Profit Margin

For every $100 in sales, Uscom Limited keeps $-1.28 as profit after all expenses.

-1.28%

Operating Margin

Core operations generate -1.45 in profit for every $100 in revenue, before interest and taxes.

-1.45%

ROE

Management delivers $-3.58 in profit for every $100 of shareholder equity.

-3.58%

ROA

Uscom Limited generates $-1.02 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.02%

Following the Money - Real Cash Generation

Operating Cash Flow

Uscom Limited generates limited operating cash flow of $-3.63M, signaling weaker underlying cash strength.

$-3.63M

Free Cash Flow

Uscom Limited generates weak or negative free cash flow of $-3.64M, restricting financial flexibility.

$-3.64M

FCF Per Share

Each share generates $-0.01 in free cash annually.

$-0.01

FCF Yield

UCM.AX converts -87.27% of its market value into free cash.

-87.27%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.71

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.03

vs 25 benchmark

P/B Ratio

Price to book value ratio

-61.05

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.21

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-59.22

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.95

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-3.58

vs 25 benchmark

ROA

Return on assets percentage

-1.02

vs 25 benchmark

ROCE

Return on capital employed

-8.16

vs 25 benchmark

How UCM.AX Stacks Against Its Sector Peers

MetricUCM.AX ValueSector AveragePerformance
P/E Ratio-0.7128.31 Better (Cheaper)
ROE-358.43%699.00% Weak
Net Margin-128.07%-130884.00% (disorted) Weak
Debt/Equity-59.220.34 Strong (Low Leverage)
Current Ratio0.952775.16 Weak Liquidity
ROA-101.69%-14469.00% (disorted) Weak

UCM.AX outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Uscom Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-40.32%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-99.79%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-670.56%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ